Loomis, Sayles & Company’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
GC
ACH
Loomis, Sayles & Company's TBI Position: Q1 2018 in Review
Loomis, Sayles & Company sold out of Trueblue (TBI) in Q1 2018, closing a stake of 282 shares — an estimated $8K sold.
Loomis, Sayles & Company first reported a position in TBI in Q3 2015 and held it in 9 quarters. The position peaked at $9K in Q1 2016. 196 funds tracked by Wall St. Rank hold TBI as of Q1 2018.
- Loomis, Sayles & Company reported no remaining Trueblue position as of Q1 2018 after selling out during the quarter.
- Loomis, Sayles & Company sold 282 Trueblue shares in Q1 2018, an estimated $8K.
- Loomis, Sayles & Company first reported a position in Trueblue in Q3 2015 and held it in 9 quarters.
- Loomis, Sayles & Company's Trueblue position peaked at $9K in Q1 2016.
- 196 funds tracked by Wall St. Rank held Trueblue as of Q1 2018.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.